Bio Works (Sweden) Buy Hold or Sell Recommendation
| BIOWKS Stock | SEK 2.76 0.06 2.13% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Bio Works Technologies AB is 'Strong Sell'. Macroaxis provides Bio Works buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BIOWKS positions. The advice algorithm takes into account all of Bio Works' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Bio Works' buy or sell advice are summarized below:
Real Value 2.65 | Hype Value 2.76 | Market Value 2.76 | Naive Value 2.71 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Bio Works Technologies AB given historical horizon and risk tolerance towards Bio Works. When Macroaxis issues a 'buy' or 'sell' recommendation for Bio Works Technologies AB, the advice is generated through an automated system that utilizes algorithms and statistical models.
Bio |
Execute Bio Works Buy or Sell Advice
The Bio recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Bio Works Technologies AB. Macroaxis does not own or have any residual interests in Bio Works Technologies AB or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Bio Works' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Very risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Moves totally opposite to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Bio Works Trading Alerts and Improvement Suggestions
| Bio Works generated a negative expected return over the last 90 days | |
| Bio Works has high historical volatility and very poor performance | |
| Bio Works has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 21.91 M. Net Loss for the year was (12.94 M) with profit before overhead, payroll, taxes, and interest of 53.01 M. | |
| Bio Works Technologies AB has accumulated about 46.35 M in cash with (13.37 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.4. | |
| Roughly 55.0% of the company shares are held by company insiders |
Bio Works Returns Distribution Density
The distribution of Bio Works' historical returns is an attempt to chart the uncertainty of Bio Works' future price movements. The chart of the probability distribution of Bio Works daily returns describes the distribution of returns around its average expected value. We use Bio Works Technologies AB price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Bio Works returns is essential to provide solid investment advice for Bio Works.
| Mean Return | -1.05 | Value At Risk | -9.66 | Potential Upside | 8.76 | Standard Deviation | 5.96 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Bio Works historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Bio Works Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Bio Works or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Bio Works' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Bio stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.98 | |
β | Beta against NYSE Composite | -0.96 | |
σ | Overall volatility | 6.04 | |
Ir | Information ratio | -0.19 |
Bio Works Volatility Alert
Bio Works Technologies AB exhibits very low volatility with skewness of -0.24 and kurtosis of 4.56. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Bio Works' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Bio Works' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Bio Works Fundamentals Vs Peers
Comparing Bio Works' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Bio Works' direct or indirect competition across all of the common fundamentals between Bio Works and the related equities. This way, we can detect undervalued stocks with similar characteristics as Bio Works or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Bio Works' fundamental indicators could also be used in its relative valuation, which is a method of valuing Bio Works by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Bio Works to competition |
| Fundamentals | Bio Works | Peer Average |
| Return On Equity | -0.66 | -0.31 |
| Return On Asset | -0.35 | -0.14 |
| Profit Margin | (1.31) % | (1.27) % |
| Operating Margin | (1.27) % | (5.51) % |
| Current Valuation | 635.01 M | 16.62 B |
| Shares Outstanding | 34.87 M | 571.82 M |
| Shares Owned By Insiders | 54.85 % | 10.09 % |
| Shares Owned By Institutions | 5.59 % | 39.21 % |
| Price To Book | 8.03 X | 9.51 X |
| Price To Sales | 19.71 X | 11.42 X |
| Revenue | 21.91 M | 9.43 B |
| Gross Profit | 53.01 M | 27.38 B |
| EBITDA | (8.6 M) | 3.9 B |
| Net Income | (12.94 M) | 570.98 M |
| Cash And Equivalents | 46.35 M | 2.7 B |
| Cash Per Share | 2.40 X | 5.01 X |
| Current Ratio | 9.14 X | 2.16 X |
| Book Value Per Share | 2.55 X | 1.93 K |
| Cash Flow From Operations | (13.37 M) | 971.22 M |
| Earnings Per Share | (0.41) X | 3.12 X |
| Target Price | 27.0 | |
| Number Of Employees | 36 | 18.84 K |
| Beta | 0.99 | -0.15 |
| Market Capitalization | 718.4 M | 19.03 B |
| Total Asset | 120.86 M | 29.47 B |
| Net Asset | 120.86 M |
Bio Works Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Bio . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Bio Works Buy or Sell Advice
When is the right time to buy or sell Bio Works Technologies AB? Buying financial instruments such as Bio Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Bio Works in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Banks Thematic Idea Now
Banks
Large and small money and credit banks and credit services. The Banks theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Banks Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Bio Works Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Complementary Tools for Bio Stock analysis
When running Bio Works' price analysis, check to measure Bio Works' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Works is operating at the current time. Most of Bio Works' value examination focuses on studying past and present price action to predict the probability of Bio Works' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Works' price. Additionally, you may evaluate how the addition of Bio Works to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |